V

    Vivos Therapeutics Inc (VVOS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.20
    -0.03 (-12.85%)

    Market Cap: $4.52M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    30%(7/23)
    Avg Surprise
    -21.16%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.30
    Range$-0.54 - $-0.12
    4 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.25+16.3%
    60d ago$-0.42-38.8%
    30d ago$-0.30+0.0%
    7d ago$-0.30+0.0%
    Current$-0.30
    Revenue Consensus
    $5M
    Range$5M - $5M
    1 analysts
    Dec 31, 2026
    EPS Consensus$-0.20
    Range$-0.99 - $0.40
    4 analysts
    Revenue Consensus
    $6M
    Range$6M - $6M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.20---
    Sep 26EST
    		-$-0.30---
    Jun 26
    		$-0.31$-0.42+26.19%Beat+43.6%
    Mar 26
    		$-0.52$-0.45-15.56%Miss-15.6%
    Dec 25
    		$-0.58$-0.49-17.17%Miss-107.1%
    Sep 25
    		$-0.49$-0.51+3.92%Beat-22.5%
    Jun 25
    		$-0.55$-0.38-44.74%Miss+8.3%
    Mar 25
    		$-0.45$-0.44-2.27%Miss+72.4%
    Dec 24
    		$-0.28$-0.43+34.88%Beat+90.8%
    Sep 24
    		$-0.40$-0.70+42.86%Beat+87.0%
    Jun 24
    		$-0.60$-1.05+42.86%Beat+84.6%
    Mar 24
    		$-1.63$-1.16-40.52%Miss-209.4%
    Dec 23
    		$-3.05$-1.90-60.53%Miss-1425.0%
    Sep 23
    		$-3.08$-3.00-2.67%Miss+52.6%
    Jun 23
    		$-3.89$-3.50-11.14%Miss-1289.3%
    Mar 23
    		$1.49N/A+131.37%Beat+118.6%
    Dec 22
    		$-0.20$-0.22+9.09%Beat+41.2%
    Sep 22
    		$-6.50$-6.25-4.00%Miss+0.0%
    Jun 22
    		$-0.28$-0.25-12.00%Miss+94.1%
    Mar 22
    		$-8.01$-6.50-23.23%Miss-68.6%
    Dec 21
    		$-0.34$-0.25-36.00%Miss+61.4%
    Sep 21
    		$-6.50$-4.62-40.69%Miss-2726.1%
    Jun 21
    		$-4.75$-4.50-5.56%Miss-2803.4%
    Mar 21
    		$-4.75$-4.25-11.76%Miss-2549.2%
    Dec 20
    		$-0.88$-0.16-450.00%Miss-390.8%
    Sep 20
    		$-0.23$0.00N/AMiss+14.7%
    Jun 20
    		$-0.16$0.00N/AMiss+27.6%
    Mar 20
    		$-0.18$0.00N/AMiss+20.6%
    Dec 19
    		$-0.18$0.00N/AMiss-
    Jun 19
    		$-0.27$0.00N/AMiss-
    Mar 19
    		$-0.23$0.00N/AMiss-
    Dec 18
    		$-0.23$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.10EV/EBITDA-0.21x
    Price/FCF-0.14xFCF Yield-703.01%
    Profitability
    Profit Margin-121.80%Operating Margin-93.60%
    ROE-8585.00%ROIC-468.32%
    Financial Health
    Debt/Equity-2.13xInterest Coverage-8.33x
    Current Ratio0.21xQuick Ratio0.21x
    Trading Statistics
    Beta6.09Avg Volume29.03M
    52-Week High$4.6352-Week Low$0.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.26
    SMA 20$0.30
    SMA 50$0.38
    SMA 200$1.18
    EMA 10$0.26
    EMA 20$0.29
    EMA 50$0.40
    EMA 200$1.18

    MACD

    Line: -0.05Signal: -0.04Hist: -0.00

    ADX

    ADX: 12.7+DI: 34.2-DI: 18.6

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down100.0
    PSAR$0.17

    Bollinger Bands

    Upper Band$0.40
    Lower Band$0.19
    %B Position7222%(Upper)
    Band Width0.03

    RSI (14-Day)

    Oversold
    26.6

    Momentum Oscillators

    Stoch %K9.2
    Stoch %D7.8
    Williams %R-89.9
    ROC (10d)-34.9%
    Momentum-0.11
    CCI (20d)-61.3
    MFI (14d)95.5

    Volatility Measures

    ATR (14d)$0.06(28.9%)
    StdDev (20d)0.05
    Hist Vol143.1%(High)

    Volume Flow

    VWAP$0.27
    OBV-442.2M
    AD Line-505.2M
    CMF (20d)-0.728

    Volume Metrics

    Avg Vol (20d)30.5M
    Vol Ratio17.3x(High)
    VWMA (20d)$0.22

    Pivot Points

    R3$0.31
    R2$0.29
    R1$0.26
    Pivot Point$0.24
    S1$0.21
    S2$0.19
    S3$0.16

    Advanced Oscillators

    TSI-34.13
    Ultimate Osc22.7
    KST-341.51

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.15M$5.14M$3.82M$6.78M$3.82M$3.02M$3.70M$3.86M$4.05M$3.42M$3.25M$3.30M
    Cost of Revenue$2.20M$2.08M$838,000$2.85M$1.71M$1.51M$1.60M$1.53M$1.40M$1.48M$1.16M$1.55M
    Gross Profit$2.95M$3.06M$2.99M$3.94M$2.11M$1.51M$2.10M$2.33M$2.65M$1.94M$2.09M$1.75M
    Operating Expenses$7.78M$9.67M$9.36M$8.67M$6.97M$5.43M$4.90M$4.98M$4.59M$5.72M$6.22M$5.39M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$7.11M$8.97M$8.54M$7.88M$6.41M$4.89M$4.35M$4.49M$4.12M$4.92M$5.47M$4.60M
    Operating Income$-4,825,000$-6,615,000$-6,377,000$-4,734,000$-4,865,000$-3,918,000$-2,805,000$-2,645,000$-1,936,000$-3,785,000$-4,134,000$-3,640,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$698,000$1.14M$576,000$666,000$148,000$0$22,000$0$0$0$125,000$0
    Income Before Tax$-5,523,000$-7,751,000$-6,953,000$-5,400,000$-5,013,000$-3,864,000$-2,827,000$-2,616,000$-1,930,000$-3,763,000$-4,259,000$-2,093,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,523,000$-7,751,000$-6,953,000$-5,400,000$-5,013,000$-3,864,000$-2,827,000$-2,616,000$-1,930,000$-3,763,000$-4,259,000$-2,093,000
    EBITDA$-5,012,000$-7,297,000$-6,511,000$-5,016,000$-4,707,000$-3,687,000$-2,683,000$-2,470,000$-1,785,000$-3,617,000$-4,110,000$-1,944,000
    EBIT$-5,523,000$-7,751,000$-6,953,000$-5,400,000$-5,013,000$-3,864,000$-2,827,000$-2,616,000$-1,930,000$-3,763,000$-4,259,000$-2,093,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VVOS

    News

    Vivos Therapeutics reports 212% rise in Nevada patient referrals

    Vivos Therapeutics (NASDAQ:VVOS) announced a 212% increase in new obstructive sleep apnea patient referrals to its Nevada Sleep & Airway Medicine Centers over the most recent six-week period. The company attributes this growth to operational and personnel changes and is preparing to open a new 8,100 square foot facility in Henderson, Nevada, next week, expecting further revenue growth from its Henderson operations.

    Investing.com•8/25/26•
    Bullish

    Vivos' Nevada sleep referrals rose 212% before a new center opens

    Vivos Therapeutics reported a significant 212% increase in average weekly new obstructive sleep apnea (OSA) patient referrals in its Nevada Sleep & Airway Medicine Centers over the past six weeks, with referrals nearly five-folding since June 1st. This growth comes as the company prepares to open an 8,100 sq. ft. sleep testing and treatment facility in Henderson, Nevada, on August 27, 2026. Despite a negative market reaction to the news, Vivos anticipates further revenue growth from its Henderson operations once the new, larger facility is fully operational, aiming to address the high demand for OSA treatment.

    Stock Titan•8/25/26•
    Neutral

    Vivos Therapeutics Inc (VVOS) Stock News Today

    This article provides the latest stock news for Vivos Therapeutics Inc (VVOS), highlighting that its Q2 2026 earnings call reported a 35% revenue increase, though liquidity risks persist. The stock closed at $0.297 with a 6.45% gain on August 21st.

    TradingKey•8/22/26•
    Neutral

    Vivos Therapeutics opens Henderson facility with $10M capacity

    Vivos Therapeutics, Inc. (NASDAQ:VVOS) announced the grand opening of a diagnostic and treatment center in Henderson, Nevada, on August 27. This new facility is expected to more than double the company's annual production capacity in Henderson to over $10 million and will employ up to 30 personnel. The center offers comprehensive diagnostic testing and various treatment options for obstructive sleep apnea and other sleep disorders, representing Vivos's "most refined platform model."

    Investing.com•8/20/26•
    Bullish

    Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually

    Vivos Therapeutics is opening a new state-of-the-art sleep center in Henderson, Nevada, on August 27, 2026, which is projected to more than double the company's annual revenue production capacity to over $10 million. This expansion aims to meet increasing demand for obstructive sleep apnea (OSA) and sleep disorder treatments, employing up to 30 staff members. The facility will offer comprehensive diagnostic and treatment services, including FDA-cleared therapies, to address the significant number of Nevadans with undiagnosed sleep apnea.

    Quiver Quantitative•8/20/26•
    Bullish

    Frequently Asked Questions About VVOS

    Does VVOS pay dividends?
    Vivos Therapeutics Inc (VVOS) does not currently pay a regular dividend.
    What is VVOS's market cap?
    Vivos Therapeutics Inc (VVOS) has a market capitalization of $4.52M with a current stock price of $0.20.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In